公司
Model N supports the complex business needs of the world’s leading brands in pharmaceutical, medical device, high tech, manufacturing and semiconductors across more than 120 countries, including Pfizer, AstraZeneca, Sanofi, Gilead, Abbott, Stryker, AMD, Micron, Seagate, STMicroelectronics, NXP, Sesotec, and Southern States.
公司
Model N supports the complex business needs of the world’s leading brands in pharmaceutical, medical device, high tech, manufacturing and semiconductors across more than 120 countries, including Pfizer, AstraZeneca, Sanofi, Gilead, Abbott, Stryker, AMD, Micron, Seagate, STMicroelectronics, NXP, Sesotec, and Southern States.
公司
Model N supports the complex business needs of the world’s leading brands in pharmaceutical, medical device, high tech, manufacturing and semiconductors across more than 120 countries, including Pfizer, AstraZeneca, Sanofi, Gilead, Abbott, Stryker, AMD, Micron, Seagate, STMicroelectronics, NXP, Sesotec, and Southern States.
借鉴2020年调查了收入高科技的状态高科技高管主要研究成果。
尽管技术的最新发展,高管一致认为,收益管理已经发展越来越复杂和收入问题的潜在影响估计在数万亿美元的高科技产业。188金宝搏体育从调查结果的收入报告,汇编的2020年国家他们目前主要发现从最近的负责收益管理在高科技,半导体306 C级管理人员的调查,和电子元件制造行业从行业专家的意见。188金宝搏体育
在此点播会议,察南格林伯格,高级副总裁兼通用汽车高科技的型号N和Syed阿拉姆,埃森哲的半导体实践的全球领导者,将讨论收入管理的挑战是如何为商业成功带来严重影响和企业如何应对。188金宝搏体育
听着这见地的交谈,其中包括以下主题:
格林伯格视察南
高级副总裁兼总经理,型号N高科技赛义德·阿拉姆
全球铅 - 半导体实践,埃森哲感谢您对示范N.的兴趣请提交表格,我们的销售团队将在24小时内与您联系。
我们会尽快给你24小时内。